1. A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
    Yan Lv et al, 2023, Genes & Diseases CrossRef
  2. Lectins as modulators of autophagy in cancer immunotherapy
    Valerie R. Wiersma, 2020, Autophagy in Immune Response: Impact on Cancer Immunotherapy CrossRef
  3. Elevated Levels of Galectin-9 but Not Osteopontin in HIV and Tuberculosis Infections Indicate Their Roles in Detecting MTB Infection in HIV Infected Individuals
    Ashwini Shete et al, 2020, Frontiers in Microbiology CrossRef
  4. Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
    Xinrui Li et al, 2022, Frontiers in Genetics CrossRef
  5. Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
    Tesfay M. Godefa et al, 2022, Cancers CrossRef
  6. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
    Minpu Zhang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  7. Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
    Dan Liu et al, 2023, Biomarker Research CrossRef
  8. A nutrigenetic approach for investigating the chemopreventive effects of black raspberries during the development of preneoplastic esophagi in rats
    Pan Pan et al, 2018, Journal of Berry Research CrossRef
  9. A galectin-9 involved in the microbial recognition and haemocyte autophagy in the Pacific oyster Crassostrea gigas
    Qian Yang et al, 2023, Developmental & Comparative Immunology CrossRef
  10. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model
    Liusheng Wu et al, 2022, Anti-Cancer Drugs CrossRef
  11. The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
    Anna Andrzejczak et al, 2023, International Journal of Molecular Sciences CrossRef
  12. Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma
    Rina Nakajima et al, 2019, Journal of Dermatological Science CrossRef
  13. The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
    Xi-Yang Tang et al, 2022, Cancers CrossRef
  14. Glycan–Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them
    Stefanie Maria Kremsreiter et al, 2021, International Journal of Molecular Sciences CrossRef
  15. Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix
    Antonio Palumbo et al, 2020, Cells CrossRef
  16. Targets for Renal Carcinoma Growth Control Identified by Screening FOXD1 Cell Proliferation Pathways
    Kyle H. Bond et al, 2022, Cancers CrossRef
  17. Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
    Taiga Chiyo et al, 2019, International Journal of Molecular Sciences CrossRef
  18. Lectins as Analytical Tools
    Fatima Enam, 2021, Comprehensive Glycoscience CrossRef
  19. Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection
    Stephen T. Yeung et al, 2022, Frontiers in Immunology CrossRef
  20. The interrelation of galectins and autophagy
    Lujuan Zheng et al, 2023, International Immunopharmacology CrossRef
  21. 2-Methyl 2-butanol suppresses human retinoblastoma cells through cell cycle arrest and autophagy
    Xiangyun Li et al, 2018, Brazilian Journal of Medical and Biological Research CrossRef
  22. Profiles of autophagy-related genes in esophageal adenocarcinoma
    Lei Zhu et al, 2020, BMC Cancer CrossRef
  23. Galectin-9 in Gastroenterological Cancer
    Asahiro Morishita et al, 2023, International Journal of Molecular Sciences CrossRef